Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | KDM5A | P29375 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12426344 | 0.90 | — | — | |
| SCHEMBL7007846 | 0.88 | TSHR (0.39) | KDM5A | |
| SCHEMBL6887685 | 0.82 | HRH4 (0.33) | — | |
| SCHEMBL466343 | 0.78 | TSHR (0.40) | — | |
| SCHEMBL896 | 0.78 | TSHR (0.46) | CA12CA1CA9KDM5AMAPT | |
| SCHEMBL3904839 | 0.78 | TSHR (0.46) | CA12CA1CA9KDM5AMAPT | |
| SCHEMBL27566038 | 0.78 | TSHR (0.46) | CA12CA1CA9KDM5AMAPT | |
| Ethane SCHEMBL4431820 | 0.74 | CA12 (0.43) | CA12CA1CA9KDM5AMAPT | |
| Water SCHEMBL8722192 | 0.74 | CA12 (0.43) | CA12CA1CA9KDM5AMAPT | |
| SCHEMBL1897739 | 0.74 | CA12 (0.43) | CA12CA1CA9KDM5AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713146-B2 | SINGLY RECORDABLE COMPACT DISC (CD-R) | BAYER AKTIENGESELLSCHAFT (DE) | 2004-03-30 | — | — | US | claimed |
| US-20020127366-A1 | Optical data stores containing a Co-phthalocyanine complex in the information layer recordable using light | LANXESS DEUTSCHLAND GMBH (DE) | 2002-09-12 | — | — | US | claimed |
| US-20250387490-A9 | IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250064938-A1 | IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2023133089-A1 | IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-13 | — | — | WO | disclosed |
| US-6713146-B2 | SINGLY RECORDABLE COMPACT DISC (CD-R) | BAYER AKTIENGESELLSCHAFT (DE) | 2004-03-30 | — | — | US | disclosed |
| EP-1322906-A1 | OPTICAL DATA STORAGE DEVICE CONTAINING A CO-PHTHALOCYANIN COMPLEX IN THE OPTICALLY WRITABLE INFORMATION LAYER | Bayer Aktiengesellschaft (DE) | 2003-07-02 | — | — | EP | disclosed |
| US-20020127366-A1 | Optical data stores containing a Co-phthalocyanine complex in the information layer recordable using light | LANXESS DEUTSCHLAND GMBH (DE) | 2002-09-12 | — | — | US | disclosed |
| WO-2002025205-A1 | OPTICAL DATA STORAGE DEVICE CONTAINING A CO-PHTHALOCYANIN COMPLEX IN THE OPTICALLY WRITABLE INFORMATION LAYER | BAYER AKTIENGESELLSCHAFT (DE) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064938-A1 | IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING | TTR, FABP1, PYGL | CA12 4443/4885CA1 4386/4885CA9 3685/4885 |
| US-20250387490-A9 | IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING | SLC10A1, TTR, FABP1 | CA12 2038/4885CA1 2666/4885CA9 2191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.